2m 2m 2m 2m 2m 2m 2m
RECURSN PHARMA-A (RXRX)
NASDAQ
$3.01+$0.005 (+0.17%)
Price as of Aug 03, 2026 8:42 AM EDT- $1.6BMarket Cap
- -47.18%1-Year Change
- BiotechnologyIndustry
RECURSN PHARMA-A (RXRX)
$3.01+$0.005 (+0.17%)
RXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.00 | ||
Change | -$0.04 (-1.32%) | ||
Open | $3.09 | ||
High | $3.10 | ||
Low | $2.95 | ||
Previous Close | $3.04 | ||
Volume | 15,329,356 | ||
30-Day Average Volume | 22,969,480 | ||
1-Week Change | 1.35% | ||
1-Month Change | -18.26% | ||
1-Year Change | -47.18% | ||
3-Year Change | -78.75% | ||
5-Year Change | -90.12% | ||
Fundamentals | |||
Shares Outstanding | 524.7M | ||
Total Assets | $1.3B | ||
Market Cap | $1.6B | ||
Enterprise Value | $936.0M | ||
Period: QTR TTM FY | |||
Revenue | $6.3M | ||
Net Income | -$117.5M | ||
Free Cash Flow | -$81.4M | ||
EBIT | -$122.1M | ||
EBITDA | -$102.4M | ||
Net Working Capital | $579.9M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 149 | ||
P/B | 2 | ||
P/E | -14 | ||
PEG | 2 | ||
Price/Free Cash Flow | -19 | ||
Price/Operating Cash Flow | -19 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue